(Q62104918)

English

UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

UARK 2003-25: A Phase I/II Open Label Study of IV Busulfan (Busulfex®) in Multiple Myeloma Patients Older Than 65 Years of Age or With Renal Insufficiency (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

University of Arkansas

0 references

country

United States of America

0 references

start time

June 2004

0 references

end time

October 2009

0 references

number of participants

14

0 references

research intervention

busulfan

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

research site

University of Arkansas

0 references

research subject recruitment status

terminated

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00113919

0 references

(Q62104918)

UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)